A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

NCT03710681 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate-to-severe Plaque Psoriasis

Interventions

BIOLOGICAL: SHR-1314

Sponsor

Jiangsu HengRui Medicine Co., Ltd.